相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Sachchida Nand Rai et al.
NEUROTOXICITY RESEARCH (2019)
Huntington's disease: a clinical review
P. McColgan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Stimulation of S1PR(5) with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease
Alba Di Pardo et al.
HUMAN MOLECULAR GENETICS (2018)
The S1P Axis: New Exciting Route for Treating Huntington's Disease
Alba Di Pardo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes
Jose F. Moruno-Manchon et al.
CELL DEATH & DISEASE (2018)
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
Alba Di Pardo et al.
FRONTIERS IN NEUROSCIENCE (2018)
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
Maria Jimenez-Sanchez et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease
Jose F. Moruno-Manchon et al.
HUMAN MOLECULAR GENETICS (2017)
Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
Alba Di Pardo et al.
NEURAL REGENERATION RESEARCH (2017)
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
Sinead O'Sullivan et al.
NEUROPHARMACOLOGY (2017)
Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements
Leila Pirhaji et al.
NATURE COMMUNICATIONS (2017)
De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease
Alba Di Pardo et al.
FRONTIERS IN NEUROSCIENCE (2017)
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo et al.
SCIENTIFIC REPORTS (2017)
Sphingosine 1-phosphate - A double edged sword in the brain
Indulekha Karunakaran et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Revealing disease-associated pathways by network integration of untargeted metabolomics
Leila Pirhaji et al.
NATURE METHODS (2016)
Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models
Alba Di Pardo et al.
FRONTIERS IN NEUROSCIENCE (2016)
Treating the whole body in Huntington's disease
Jeffrey B. Carroll et al.
LANCET NEUROLOGY (2015)
Autophagy in Huntington disease and huntingtin in autophagy
Dale D. O. Martin et al.
TRENDS IN NEUROSCIENCES (2015)
Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy
Renbao Chang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy
Jose Felix Moruno Manchon et al.
SCIENTIFIC REPORTS (2015)
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
Alba Di Pardo et al.
HUMAN MOLECULAR GENETICS (2014)
Coupling between endocytosis and sphingosine kinase 1 recruitment
Hongying Shen et al.
NATURE CELL BIOLOGY (2014)
Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons
Hyun Lee et al.
NATURE COMMUNICATIONS (2014)
Identification of a candidate therapeutic autophagy-inducing peptide
Sanae Shoji-Kawata et al.
NATURE (2013)
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Gregory T. Kunkel et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease
Carmela Giampa et al.
PLOS ONE (2013)
The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients
Silke Metzger et al.
PLOS ONE (2013)
Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
Michelle E. Ehrlich
NEUROTHERAPEUTICS (2012)
Sphingosine-1-phosphate signaling and its role in disease
Michael Maceyka et al.
TRENDS IN CELL BIOLOGY (2012)
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Albert Giralt et al.
MOLECULAR NEURODEGENERATION (2011)
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
Betty Soliven et al.
NEUROLOGY (2011)
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
Vittorio Maglione et al.
JOURNAL OF NEUROSCIENCE (2010)
Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies
Nicole O'Brien et al.
JOURNAL OF LIPID RESEARCH (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice
Miriam Matamales et al.
PLOS ONE (2009)
Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation
G Lavieu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway
A Yamamoto et al.
JOURNAL OF CELL BIOLOGY (2006)
Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation
V Maglione et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea
V Maglione et al.
NEUROSCIENCE LETTERS (2006)
Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease
V Maglione et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
I Sánchez et al.
NATURE (2003)
Sphingosine-l-phosphate and lipid phosphohydrolases
H Le Stunff et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
分享论文
